Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 100 participants.
Also called NCT01336348
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 100 participants
- Sponsor
- Università degli Studi di Ferrara
- Registry
-
NCT01336348
-
- Other papers using this trial's data
- Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT01336348. Randomized; single masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2011-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse
- Acronym
- FABOLUS PRO
- Condition
- ST Segment Elevation Myocardial Infarction
- Intervention (Drug)
- Prasugrel
- Intervention (Drug)
- Tirofiban
- Lead sponsor
- Università degli Studi di Ferrara
Record details
- Record id
cardio:ct-nct01336348- Content hash
58a4356d85e4f5302f308d98855f8d360480e98d0732c06dfcd316f98274ffad